biOasis Receives Compelling Data From Texas Tech University On Its Herceptin(R) BT2111 Program - Yahoo! Finance

biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that research underway at Texas Tech University Health Sciences Center (TTUHSC) has yielded some compelling data on preclinical studies designed to evaluate the pharmacokinetics of BT2111 (a proprietary conjugate of Transcend and Herceptin®) in animal models of breast cancer metastasis to the brain.

Read the full story >>

Related Stories

Molecular Pathology Preceptorship: Unmatched Value and Experience

Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.

Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing

Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.

TTUHSC School of Nursing to Celebrate New YWCA Location

Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.

Recent Stories

Health

Measles Outbreak: What to Know From The Future of Health

Kelissa Huse, an assistant professor and laboratory manager in the Molecular Pathology Program at TTUHSC, spoke about measles, the outbreak and what West Texans needs to know about the disease.

Education

Santos Named Department of Surgery Chair for TTUHSC School of Medicine in Lubbock

As the new Department of Surgery chair for the School of Medicine in Lubbock, Ariel Santos, M.D., M.P.H., seeks to elevate TTUHSC’s role as the Hub of Surgery for West Texas.

Health

Covenant Health Brings Kidney Transplant Surgery Back to West Texas

The Kidney Transplant Program at Covenant Medical Center will provide life-changing opportunities for patients suffering from end-stage renal disease (ESRD) and chronic kidney conditions.